Clinical Trial: A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07731685) titled 'A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases' on July 23.

Brief Summary: This is a randomized, double-blind, placebo-controlled Phase Ib study evaluating the safety and efficacy of VC004 capsules for the relief of moderate-to-severe pain associated with bone metastases

Study Start Date: July 30

Study Type: INTERVENTIONAL

Condition: Pain in Bone Metastases

Intervention: DRUG: VC004 low dose

VC004 low dose BID

DRUG: VC004 high dose

VC004 high dose BID

DRUG: VC004 placebo

VC004 placebo BID

Recruitment Status: NOT_YET_RECRUITI...